FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207281690> ?p ?o ?g. }

• W3207281690 endingPage "117693512110492" @default.
• W3207281690 startingPage "117693512110492" @default.
• W3207281690 abstract "Introduction: Epidermal growth factor receptor (EGFR) is a transmembrane protein that belongs to the ErbB/HER-family of tyrosine kinase receptors. Somatic mutations and overexpression of EGFR have been reported to play a vital role in cancer cell development and progression, including cell proliferation, differentiation, angiogenesis, apoptosis, and metastatic spread. Hence, EGFR is an important therapeutic target for the treatment of various types of epithelial cancers. Somatic mutations have led to resistance to clinically approved synthetic EGFR inhibitors. Furthermore, synthetic EGFR inhibitors have been associated with several side effects. Thus, there is a need to develop novel EGFR inhibitors with an acceptable biosafety profile and high efficacy. Methods: Herein, we employed structural bioinformatics and theoretical chemistry techniques via molecular docking, molecular mechanics generalized Born surface area (MM-GBSA) calculation, density functional theory analysis (DFT), and pharmacokinetic study to identify novel EGFR inhibitors. Results: The stringent molecular docking and MM-GBSA calculations identified MET 793, LYS 745, PHE 723, ASP 855, ARG 411, and THR 854 as principal amino acid residues for EGFR-ligands interactions. Furthermore, Colocasia affinis Schott compounds exhibited higher binding energy and more stable interactions than the reference compound (gefitinib). DFT analysis also ascertains better bioactivity and chemical reactivity of C. affinis Schott with favorable intramolecular charge transfer between electron-donor and electron acceptor groups. The pharmacokinetic profile of C. affinis Schott bioactive compounds satisfies Lipinski’s rule of five assessment. Conclusion: Collectively, C. affinis Schott compounds demonstrated higher inhibitory potentials against EGFR and better pharmacological properties when compared with gefitinib. C. affinis Schott compounds are therefore suggested as promising therapeutic EGFR inhibitors for cancer treatment." @default.
• W3207281690 created "2021-10-25" @default.
• W3207281690 creator A5000698544 @default.
• W3207281690 creator A5004901619 @default.
• W3207281690 creator A5030957985 @default.
• W3207281690 creator A5030995602 @default.
• W3207281690 creator A5051091546 @default.
• W3207281690 creator A5058018521 @default.
• W3207281690 creator A5061853767 @default.
• W3207281690 creator A5067217936 @default.
• W3207281690 creator A5081114188 @default.
• W3207281690 date "2021-01-01" @default.
• W3207281690 modified "2023-10-06" @default.
• W3207281690 title "Computational Evaluation of Bioactive Compounds from <i>Colocasia affinis</i> Schott as a Novel EGFR Inhibitor for Cancer Treatment" @default.
• W3207281690 cites W1822850048 @default.
• W3207281690 cites W1964321121 @default.
• W3207281690 cites W1965173894 @default.
• W3207281690 cites W1985294501 @default.
• W3207281690 cites W1985588649 @default.
• W3207281690 cites W1995292068 @default.
• W3207281690 cites W2003589276 @default.
• W3207281690 cites W2004439203 @default.
• W3207281690 cites W2014858249 @default.
• W3207281690 cites W2036926586 @default.
• W3207281690 cites W2047321776 @default.
• W3207281690 cites W2055787813 @default.
• W3207281690 cites W2070727232 @default.
• W3207281690 cites W2083960841 @default.
• W3207281690 cites W2093036951 @default.
• W3207281690 cites W2094882473 @default.
• W3207281690 cites W2095719702 @default.
• W3207281690 cites W2108886196 @default.
• W3207281690 cites W2127167377 @default.
• W3207281690 cites W2131361386 @default.
• W3207281690 cites W2131487381 @default.
• W3207281690 cites W2135732933 @default.
• W3207281690 cites W2137600224 @default.
• W3207281690 cites W2139243915 @default.
• W3207281690 cites W2143981217 @default.
• W3207281690 cites W2149412903 @default.
• W3207281690 cites W2151016309 @default.
• W3207281690 cites W223345270 @default.
• W3207281690 cites W2239621362 @default.
• W3207281690 cites W2316765704 @default.
• W3207281690 cites W2326101495 @default.
• W3207281690 cites W2522938575 @default.
• W3207281690 cites W2593117517 @default.
• W3207281690 cites W2620474869 @default.
• W3207281690 cites W2770818064 @default.
• W3207281690 cites W2888936354 @default.
• W3207281690 cites W2922051353 @default.
• W3207281690 cites W2941987622 @default.
• W3207281690 cites W2953226611 @default.
• W3207281690 cites W3010872301 @default.
• W3207281690 cites W3039292359 @default.
• W3207281690 cites W3084804014 @default.
• W3207281690 cites W3121819094 @default.
• W3207281690 cites W3158230721 @default.
• W3207281690 doi "https://doi.org/10.1177/11769351211049244" @default.
• W3207281690 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8504293" @default.
• W3207281690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34646061" @default.
• W3207281690 hasPublicationYear "2021" @default.
• W3207281690 type Work @default.
• W3207281690 sameAs 3207281690 @default.
• W3207281690 citedByCount "15" @default.
• W3207281690 countsByYear W32072816902022 @default.
• W3207281690 countsByYear W32072816902023 @default.
• W3207281690 crossrefType "journal-article" @default.
• W3207281690 hasAuthorship W3207281690A5000698544 @default.
• W3207281690 hasAuthorship W3207281690A5004901619 @default.
• W3207281690 hasAuthorship W3207281690A5030957985 @default.
• W3207281690 hasAuthorship W3207281690A5030995602 @default.
• W3207281690 hasAuthorship W3207281690A5051091546 @default.
• W3207281690 hasAuthorship W3207281690A5058018521 @default.
• W3207281690 hasAuthorship W3207281690A5061853767 @default.
• W3207281690 hasAuthorship W3207281690A5067217936 @default.
• W3207281690 hasAuthorship W3207281690A5081114188 @default.
• W3207281690 hasBestOaLocation W32072816902 @default.
• W3207281690 hasConcept C121608353 @default.
• W3207281690 hasConcept C147597530 @default.
• W3207281690 hasConcept C159110408 @default.
• W3207281690 hasConcept C170493617 @default.
• W3207281690 hasConcept C185592680 @default.
• W3207281690 hasConcept C25057246 @default.
• W3207281690 hasConcept C2777506169 @default.
• W3207281690 hasConcept C2779413316 @default.
• W3207281690 hasConcept C2779438470 @default.
• W3207281690 hasConcept C2779786085 @default.
• W3207281690 hasConcept C2780580887 @default.
• W3207281690 hasConcept C41685203 @default.
• W3207281690 hasConcept C502942594 @default.
• W3207281690 hasConcept C530470458 @default.
• W3207281690 hasConcept C54355233 @default.
• W3207281690 hasConcept C55493867 @default.
• W3207281690 hasConcept C59593255 @default.
• W3207281690 hasConcept C71924100 @default.
• W3207281690 hasConcept C86803240 @default.
• W3207281690 hasConcept C98274493 @default.

• next